Building extension commencement notices — Clondalkin

Enabling works including modifications and extensions to existing service plant for New 5 storey bio- pharmaceutical manufacturing facility plus associated works to south of existing Drug Substance (DS) Building for Pfizer Grangecastle.

Floor area stated for this source: 28,638 m².

New 5 storey bio- pharmaceutical manufacturing building - DS2 - Phase 1. 20,320 sq meters floor area and 28.2 meters high with single storey link 750 sq meters floor area - located to south of the existing DS1 building at Pfizer Ireland Pharmaceuticals, Grange Castle Business Park, Nangor Road, Clondalkin, Dublin 22. Associated site works, utilities provision, plant revisions and minor existing building amendments on the site not subject to Fire Safety Certificate but part of permitted development under Planning Permission SD16A/0236 are subject to Commencement Notice Without Documentation Ref 8381155.

Floor area stated for this source: 21,070 m².

Non-building works associated with the development subject to Planning Permission Ref SD16A/0236. This includes siteworks, parking, various alterations to existing site services and facilities to accommodate the provision of the permitted buildings, works for new and re-located items of plant and equipment and pipe bridge structures, landscaping and boundary works plus building works not subject to Fire Safety Certificate applications and subsequent Commencement Notice with Documentation. All the above works are subject to the conditions of 10-year Planning Permission Grant SD16A/0236 of 10th October 2016 and described in Planning Application documentation.